Current Interventional Radiology News and Events | Page 25

Current Interventional Radiology News and Events, Interventional Radiology News Articles.
Sort By: Most Relevant | Most Viewed
Page 25 of 25 | 1000 Results
Positive results for non surgical heart valve replacement
Researchers are reporting positive results from a landmark clinical trial of an investigational aortic valve that is deployed with a catheter, without open heart surgery. (2013-11-04)

Voxel-based magnetic resonance morphometry in Parkinson's disease patients
Non-motor symptoms, including abnormalities in cognition, mental behaviors, autonomic nerves and sensory perception, have the greatest effect on the quality of in Parkinson's disease patient life. Voxel-based morphometry can be used to quantitatively compare structural differences and func-tional changes of gray matter in subjects. (2013-11-03)

Non-radiologists perform majority of ultrasound-guided invasive procedures, study suggests
The November issue of the Journal of the American College of Radiology focuses on a variety of issues relating to clinical practice, practice management, health services and policy, and radiology education and training. Topics to be covered include imaging recommendations for acute stroke and transient ischemic attack patients; CT scan parameters and radiation dose; optimizing radiation use during fluoroscopic procedures; and the increasing role of non-radiologists in performing ultrasound-guided invasive procedures. (2013-11-01)

Results of the FREEDOM sub study reported at TCT 2013
According to a recent study of diabetic patients who underwent revascularization for multi-vessel coronary artery disease, patients treated with insulin experienced more major adverse cardiovascular events after revascularization than those not treated with insulin. (2013-10-31)

Results of the TATORT-NSTEMI trial presented at TCT 2013
According to a new study, aspirating blood clots does not significantly reduce microvascular obstruction or reduce the risk of death in patients with non-ST-elevation myocardial infarction, when compared to standard percutaneous coronary intervention without thrombectomy. (2013-10-31)

Results of the ARCTIC-INTERRUPTION trial presented at TCT 2013
According to a new study, patients that do not experience a major cardiac event in the first year after receiving drug-eluting stent may not need to receive prolonged dual antiplatelet therapy. Results from the ARCTIC-INTERRUPTION trial were presented today at the 25th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium. Sponsored by the Cardiovascular Research Foundation, TCT is the world's premier educational meeting specializing in interventional cardiovascular medicine. (2013-10-31)

Results of the GIANT trial reported at TCT 2013
According to a new study, genetic profiling of patients undergoing percutaneous coronary intervention may help cardiology teams adjust treatment and improve ischemic outcomes for patients that do not properly metabolize thienopyridine blood thinning therapies such as clopidogrel. (2013-10-31)

Results of DUTCH PEERS (TWENTE II) trial reported at TCT 2013
Results of the DUTCH PEERS (TWENTE II) clinical trial demonstrate comparable safety and efficacy of two third-generation permanent polymer-based drug-eluting stents with low rates of adverse clinical events and establish the non-inferiority of the newest zotarolimus-eluting stent. The findings were presented today at the 25th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium. Sponsored by the Cardiovascular Research Foundation, TCT is the world's premier educational meeting specializing in interventional cardiovascular medicine. (2013-10-31)

Results of the TRANSLATE-POPS trial presented at TCT 2013
According to a new study of heart attack patients treated with percutaneous coronary intervention, free access to platelet function testing had only a modest impact on anti-clotting drug selection and dosing. Findings of the TRANSLATE-POPS trial were presented today at the 25th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium. Sponsored by the Cardiovascular Research Foundation, TCT is the world's premier educational meeting specializing in interventional cardiovascular medicine. (2013-10-31)

Results of the REPRISE II trial reported at TCT 2013
In a clinical trial, a second-generation transcatheter aortic valve demonstrated low rates of complications that are sometimes seen in transcatheter aortic valve replacement, including challenges with positioning, post-procedure paravalvular aortic regurgitation, vascular complications, and stroke. (2013-10-31)

Results of the HYBRID trial presented at TCT 2013
A hybrid approach to treating coronary artery disease that involves a (2013-10-31)

CWRU researchers aim nanotechnology at micrometastases
Researchers at Case Western Reserve University have received two grants totaling nearly $1.7 million to build nanoparticles that seek and destroy metastases too small to be detected with current technologies. They are targeting aggressive cancers that persist through traditional chemotherapy. (2013-10-31)

Results of the OPTIMIZE trial presented at TCT 2013
A new study demonstrates that some patients may not need to receive prolonged anti-clotting therapy after drug-eluting stent implantation with the Endeavor zotarolimus-eluting stent, and that shortening the duration could reduce bleeding risks and treatment costs. The OPTIMIZE clinical trial findings were presented today at the 25th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium. Sponsored by the Cardiovascular Research Foundation, TCT is the world's premier educational meeting specializing in interventional cardiovascular medicine. (2013-10-31)

Results of the CHILL-MI trial presented at TCT 2013
A clinical trial shows that rapidly cooling patients who have suffered ST-elevation myocardial infarction (STEMI, the most serious form of a heart attack) prior to restoring blood flow is safe and feasible. The findings of the CHILL-MI trial were presented today at the 25th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium. Sponsored by the Cardiovascular Research Foundation, TCT is the world's premier educational meeting specializing in interventional cardiovascular medicine. (2013-10-30)

Results of the SMART-CASE trial presented at TCT 2013
A new study shows that a conservative approach to revascularization for patients with intermediate coronary lesions determined by angiographic diameter stenosis is safe and non-inferior to an aggressive approach. Findings of the SMART-CASE trial were presented today at the 25th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium. Sponsored by the Cardiovascular Research Foundation, TCT is the world's premier educational meeting specializing in interventional cardiovascular medicine. (2013-10-30)

Results of the ADVISE II trial presented at TCT 2013
A new study supports the use of instantaneous wave-free ratio, to simplify assessment and determine the severity of coronary artery disease. ADVISE II findings were presented today at the 25th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium. Sponsored by the Cardiovascular Research Foundation, TCT is the world's premier educational meeting specializing in interventional cardiovascular medicine. (2013-10-30)

Procedural results from the RIBS V trial presented at TCT 2013
A clinical trial comparing the use of drug-eluting stents and drug-eluting balloons in treating in-stent restenosis from bare metal stents found that both techniques yielded positive long term outcomes. Findings from the RIBS V trial were presented today at the 25th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium. Sponsored by the Cardiovascular Research Foundation, TCT is the world's premier educational meeting specializing in interventional cardiovascular medicine. (2013-10-30)

Loyola cardiologist is co-editor of text on minimally invasive procedures for vascular diseases
Loyola University Medical Center interventional cardiologist Robert Dieter, M.D., is co-editor of a new authoritative textbook on minimally invasive endovascular techniques to treat vascular disease. (2013-10-30)

Results of the TRYTON trial presented at TCT 2013
A clinical trial designed to measure the effectiveness of using a dedicated side branch-covering bare metal stent in true bifurcation coronary lesions found that that the strategy was safe, but the results did not establish non-inferiority compared to the currently accepted strategy of using a single stent with provisional use of a second side branch stent when indicated. (2013-10-30)

Hippocampal and thalamic neuronal metabolism in a putative rat model of schizophrenia
Brain-derived neurotrophic factor and neuregulin 1 are important genes and signaling pathways that are altered in schizophrenia. (2013-10-30)

6-month data of the LEVANT 2 trial presented at TCT 2013
The first clinical trial in the United States to study the use of drug coated balloons for femoropopliteal artery disease found the procedure is promising for safety and efficacy at six months. Six month data of the LEVANT 2 trial was presented today at the 25th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium. Sponsored by the Cardiovascular Research Foundation, TCT is the world's premier educational meeting specializing in interventional cardiovascular medicine. (2013-10-30)

Study finds pre-hospital administration of bivalirudin substantially improves outcomes compared to heparin in heart attack patients
According to a new study, administering the blood thinner bivalirudin to patients experiencing an ST-elevation myocardial infarction (STEMI, the most serious form of a heart attack) in a pre-hospital setting can reduce the risk of death and major bleeding complications compared to heparin with optional use of glycoprotein IIb/IIIa inhibitors. (2013-10-30)

New study compares provisional and two-stent strategies for coronary bifurcation lesions
A new clinical trial shows that a two-stent technique for treatment of bifurcation lesions with a large stenotic side branch was not associated with significant improved outcomes compared to a provisional stenting approach. The findings from the Nordic-Baltic Bifurcation IV study were presented today at the 25th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium. Sponsored by the Cardiovascular Research Foundation, TCT is the world's premier educational meeting specializing in interventional cardiovascular medicine. (2013-10-30)

Results of the SORT-OUT VI trial presented at TCT 2013
A new study found that both drug-eluting stents (DES) with biocompatible polymers and DES with biodegradable polymers were associated with low major adverse coronary events, demonstrating the non-inferiority of the biocompatible polymer stents in patients undergoing percutaneous coronary intervention. The findings of the SORT-OUT VI trial were presented today at the 25th annual Transcatheter Cardiovascular Therapeutics scientific symposium. (2013-10-29)

Results of the COREVALVE EXTREME RISK trial presented at TCT 2013
In a clinical trial, a self-expanding transcatheter aortic valve met the key performance objective of reducing death and stroke in patients with severe aortic stenosis at (2013-10-29)

Results of the SAFE-PCI trial presented at TCT 2013
A clinical trial conducted exclusively in women suggests that an initial strategy of using the radial artery in the arm as the entry point for cardiac catheterization or percutaneous coronary intervention (PCI) in women has potential for reducing bleeding complications. SAFE-PCI for Women is the first registry-based randomized trial in the United States and the first multicenter trial comparing radial with femoral access in the US. (2013-10-29)

CRF and UCR announce initiation of PROSPECT II clinical trial
The Cardiovascular Research Foundation of New York, NY and the Uppsala Clinical Research Center of Uppsala, Sweden announced today the initiation of the PROSPECT (Providing Regional Observations to Study Predictors of Events in the Coronary Tree) II trial and the PROSPECT ABSORB sub study. (2013-10-28)

Stroke prevention surgery less effective than meds, lifestyle change
The final results of a stroke prevention study in patients with narrowed brain arteries confirm earlier findings: Medication plus lifestyle changes are safer and more effective at preventing stroke than a surgical technique called stenting. (2013-10-26)

Clifford Jack Jr., M.D., elected to Institute of Medicine
Clifford Jack Jr., M.D., radiologist and noted Alzheimer's disease researcher at Mayo Clinic, has been elected to the Institute of Medicine, part of the national academies. Election is considered one of the top honors in medicine. (2013-10-24)

A natural boost for MRI scans
Using an innocuous agent that is already naturally produced in the body, EPFL researchers have developed a breakthrough method that can make contrast-enhanced MRI safer and cheaper. (2013-10-21)

Vertebral augmentation for spinal fractures offers greater patient survival and overall cost savings
A study of 69,000 Medicare patient records led by Johns Hopkins researchers shows that people with spine compression fractures who undergo operations to strengthen back bones with cement survive longer and have shorter overall hospital stays than those who stick with bed rest, pain control and physical therapy. (2013-10-17)

UCLA, USC get $2M to develop stroke center network in Southland
A three-way partnership between the UCLA Stroke Center at the Ronald Reagan Medical Center, the University of Southern California (USC) Comprehensive Stroke and Cerebrovascular Center at Keck Medicine of USC, and UC Irvine has been awarded a $2 million grant from the National Institutes of Health to address those three stroke priorities. (2013-10-15)

Medical experts recommend steps to reduce risk of inadvertent harm to potentially normal pregnancies
A panel of 15 medical experts from radiology, obstetrics-gynecology and emergency medicine, convened by the Society of Radiologists in Ultrasound, recommends new criteria for use of ultrasonography to determine when a first trimester pregnancy is nonviable (no chance of progressing and resulting in a live-born baby). These new diagnostic thresholds, published Oct. 10 in the New England Journal of Medicine, would help avoid the possibility of physicians causing inadvertent harm to a potentially normal pregnancy. (2013-10-09)

Medical imaging professionals develop safety checklist to improve pediatric radiography
The October issue of the JACR focuses on a variety of issues relating to clinical practice, practice management, health services and policy, and radiology education. Topics to be covered include the evolving role of the radiologist; the increasing role of radiologists in thoracic diagnosis; the Image Gently Pediatric Digital Radiography Safety Checklist; managing incidental findings on abdominal and pelvic CT and MRI; and an analysis of radiologists' imaging workload trends by place of service. (2013-10-01)

New breast cancer imaging technique could cut down on false positives
A joint BYU-Utah research team is developing a new breast cancer screening technique that has the potential to reduce false positives, and, possibly, minimize the need for invasive biopsies. The group has created an MRI device that could improve both the process and accuracy of breast cancer screening by scanning for sodium levels in the breast. (2013-09-27)

CRF announces late breaking trials and first report investigations to be presented at TCT 2013
The Cardiovascular Research Foundation has announced the late breaking trials and first report investigations that will be presented at next month's Transcatheter Cardiovascular Therapeutics (TCT) 2013 scientific symposium. TCT, the world's premier educational meeting specializing in interventional cardiovascular medicine, will take place Oct. 28 - Nov. 1, 2013 at The Moscone Center in San Francisco, California. (2013-09-20)

UCLA doctors successfully 'vacuum' 2-foot blood clot out of patient's heart
UCLA doctors sucked a 24-inch blood clot from a man's heart using a new device that spared him from open-heart surgery. It was the first time that doctors successfully performed the procedure in California. (2013-09-18)

Fully dissolvable, temporary stent for opening heart artery blockages
The Mount Sinai Medical Center is participating in the nationwide ABSORB III clinical trial testing the performance and potential clinical benefits of a fully dissolvable and temporary drug eluting stent to open heart artery blockages. The randomized trial aims to compare the efficiency and safety of Absorb Bioresorbable Vascular Scaffolds in coronary artery disease patients and compare it to the current standard of care -- drug eluting metal stents. (2013-09-17)

Self-referral spurs unnecessary MRI exams for patients
Patients having knee MRI examinations are significantly more likely to receive a negative finding if referred by physicians who have a financial interest in the imaging equipment being used, according to a study. (2013-09-17)

MRI may predict heart attack and stroke risk in people with diabetes
Whole-body MRI may serve as a valuable noninvasive tool for assessing the risk of heart attack and stroke in diabetic patients, according to a new study. (2013-09-10)

Page 25 of 25 | 1000 Results
   First   Previous   Next      Last   
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.